The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer

Published:2020-03-06 Issue:17 Volume:39 Page:3571-3587
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

He Zongsheng,Thorrez Lieven,Siegfried Geraldine,Meulemans Sandra,Evrard Serge,Tejpar Sabine,Khatib Abdel-Majid,Creemers John W. M.

Funder

Fonds Wetenschappelijk Onderzoek

China Scholarship Council

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-020-1238-z.pdf

Reference65 articles.

1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

2. Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, et al. Oncogenic signaling pathways in the cancer genome atlas. Cell. 2018;173:321–37.

3. Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–7.

4. Van Cutsem E, Köhne C-H, Hitre E, Zaluski J, Chang Chien C-R, Makhson A, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009;360:1408–17.

5. De Roock W, De Vriendt V, Normanno N, Ciardiello F, Tejpar S. KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer. Lancet Oncol. 2011;12:594–603.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 and Carcinogenesis: Exploring the Hidden Links;Cureus;2024-08-31

2. Development and Prospects of Furin Inhibitors for Therapeutic Applications;International Journal of Molecular Sciences;2024-08-24

3. The intestinal stem cell as a target: A review;Medicine;2024-08-23

4. Advances in Personalized Oncology;Cancers;2024-08-16

5. Prevalence of and gene regulatory constraints on transcriptional adaptation in single cells;Genome Biology;2024-08-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3